Loading clinical trials...
Loading clinical trials...
SloMo2: A Process Evaluation, Effectiveness, and Cost-effectiveness Study of a Digitally Supported Therapy for Psychosis in Routine Care
Conditions
Interventions
SloMo
Locations
1
United Kingdom
South London and Maudsley NHS Foundation Trust
London, United Kingdom
Start Date
October 16, 2024
Primary Completion Date
September 1, 2027
Completion Date
December 31, 2027
Last Updated
January 26, 2026
NCT06740383
NCT05951660
NCT06505564
NCT04452175
NCT04298450
NCT03741751
Lead Sponsor
King's College London
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions